Eswatini, a small landlocked country in southern Africa, is facing a critical challenge in its fight against HIV. A new drug, known as pre-exposure prophylaxis (PrEP), has the potential to prevent new infections, yet its rollout remains limited. Last month, the Ministry of Health confirmed that only 1,200 people have received the medication, despite the country’s high HIV prevalence rate of 23.2%. Activist and community leader If Precious, who runs a local HIV awareness programme, says the lack of access is putting lives at risk.
How the Drug Works and Why It Matters
PrEP is a daily pill that reduces the risk of HIV infection by up to 99% when taken consistently. It is especially effective for high-risk groups, including sex workers, men who have sex with men, and young women. In Eswatini, where one in four adults is living with HIV, the drug could be a game-changer. However, the country’s health system is struggling to scale up distribution. Precious, who has seen the impact of the epidemic on her community, says the current supply is “no more than a drop in the ocean.”
The Ministry of Health has cited budget constraints and logistical challenges as the main barriers. “We need more funding to expand access,” said Dr. Thandiwe Dlamini, a senior health official. “But the international community has not prioritised Eswatini in the same way as other African nations.” Despite calls for increased investment, the rollout remains slow, leaving many vulnerable populations without protection.
Impact on Daily Life and the Local Economy
The shortage of PrEP has had a direct impact on daily life in Eswatini. In rural areas like Mbabane, where access to healthcare is limited, many residents rely on community-based initiatives to stay informed. Precious’s organisation, called “If Precious,” runs mobile clinics that provide education and testing. But without PrEP, these efforts are not enough to curb the spread of the virus.
The economic consequences are also significant. HIV-related illnesses strain the healthcare system and reduce workforce productivity. A 2023 report by the World Bank estimated that the epidemic costs Eswatini around 1.5% of its GDP annually. Without better access to prevention tools, the country risks falling further behind in its development goals.
Community Response and Calls for Action
Local communities have responded with both frustration and determination. In a recent meeting in Manzini, residents demanded greater transparency from the government. “We are tired of promises,” said Sipho Mthethwa, a community leader. “We need action now.” Activists have also partnered with international NGOs to push for more funding and better policies.
One such organisation, the Eswatini AIDS Foundation, has launched a public awareness campaign to highlight the importance of PrEP. “This is not just a health issue,” said spokesperson Noma Dlamini. “It’s about dignity, equality, and the future of our children.” Despite these efforts, the lack of access continues to be a major barrier.
What’s Next for Eswatini’s HIV Response?
The coming months will be crucial for Eswatini’s HIV prevention strategy. The government has pledged to increase PrEP distribution by 2025, but progress remains uncertain. International donors, including the Global Fund, are being urged to step up their support. “We need a coordinated effort,” said Dr. Dlamini. “Without it, we will continue to see preventable infections.”
For now, activists like Precious remain hopeful but wary. “We are not giving up,” she said. “But we need the world to see Eswatini’s struggle and act.” As the country continues to battle the HIV epidemic, the question remains: will the global community finally step up to meet the needs of those most at risk?
The next major review of Eswatini’s HIV strategy is scheduled for early 2025. If the government fails to meet its targets, pressure from both local and international groups is expected to intensify. For now, the fight for better access to PrEP continues, with communities hoping for change before it’s too late.
